主页 /
搜索结果：“jwh 250”

“jwh 250”的搜索结果

Quick View
Reversine

Catalog No. A13250
Quick View

添加到收藏
human A3 adenosine receptor 拮抗剂 /Aurora 抑制剂

Reversine是一种有效的人A3腺苷受体拮抗剂，Ki为0.66μM，是一种泛光A/B/C激酶抑制剂，IC50分别为12 nM/13 nM/20 nM。也用于干细胞去分化。了解更多

Product Citations (1)

Bulk Inquiry Free Sample
- Hazheen K, .et al. BuGZ facilitates loading of spindle assembly checkpoint proteins to kinetochores in early mitosis, J Biol Chem, 2020, August 20
Quick View
MK-5108 (VX-689)

Catalog No. A11410
Quick View

添加到收藏
Aurora A Kinase 抑制剂

MK-5108，也称为VX-689，是Aurora A激酶ATP结合位点的竞争性抑制剂。了解更多

Product Citations (1)

Bulk Inquiry
- Wei TW, .et al. Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA, Cancer Res, 2017, Jan 15;77(2):494-508 PMID: 28069801
Quick View
PHA-680632

Catalog No. A10714
Quick View

添加到收藏
Aurora 抑制剂

PHA-680632是Aurora A，Aurora B和Aurora C的有效抑制剂，IC50分别为27 nM，135 nM和120 nM。对于FGFR1，FLT3，LCK，PLK1，STLK2和VEGFR2/3，它的IC50高10到200倍。了解更多

Bulk Inquiry Free Sample
Quick View
TAK-901

Catalog No. A11067
Quick View

添加到收藏
Aurora Kinase A/B 抑制剂

TAK-901是一种新型Aurora A/B抑制剂，IC50为21 nM/15 nM。它不是细胞JAK2，c-Src或Abl的有效抑制剂。了解更多

Bulk Inquiry Free Sample
Quick View
AMG 900

Catalog No. A11066
Quick View

添加到收藏
Aurora Kinase 抑制剂

AMG 900是一种新型有效且高度选择性的泛Aurora激酶抑制剂，在紫杉烷抗性肿瘤细胞系中具有活性。了解更多

Product Citations (1)

Bulk Inquiry
- Tomoya Takeda, .et al. AT9283 exhibits antiproliferative effect on tyrosine kinase inhibitor-sensitive and -resistant chronic myeloid leukemia cells by inhibition of Aurora A and Aurora B, Oncol Rep, 2020, August 18
Quick View
VX-680 (MK-0457, Tozasertib)

Catalog No. A10981
Quick View

添加到收藏
Aurora Kinase 抑制剂

VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。了解更多

Product Citations (2)

Bulk Inquiry Free Sample
- Sakamoto K, .et al. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response, Leukemia, 2018, May 23 PMID: 29795241
- W. Joost Lesterhuis, .et al. Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations, Sci Rep, 2015, 5: 12298 PMID: 26193793